Globus Pallidus

Introduction

Globus Pallidus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The globus pallidus (Latin: "pale globe") is a subcortical structure of the basal-ganglia that serves as the primary output nucleus for motor information processed by the striatum. Located medial to the putamen and lateral to the internal capsule, it consists of two functionally distinct segments: the globus pallidus externus (GPe, or lateral segment) and the globus pallidus internus (GPi, or medial segment). [@vitek2012]
The GPi, together with the substantia-nigra pars reticulata (SNr), provides the final basal ganglia output to the thalamus and brainstem, tonically inhibiting thalamo-cortical activity through GABAergic projections.[@parent2020] [@abdi2015]

The globus pallidus is clinically significant in multiple neurodegenerative diseases and is a major therapeutic target for [deep-brain-stimulation](/therapeutics/deep-brain-stimulation) (DBS). GPi-DBS is a well-established treatment for parkinsons motor complications, dystonia, and huntington-pathway chorea. [@hallgren1958]
Pathological changes in the globus pallidus occur in Parkinson's Disease, Huntington's Disease, psp, neurodegeneration with brain iron accumulation (NBIA), Wilson's Disease, and other basal ganglia disorders.[@vitek2012] [@delong1990]

Anatomy

Segments

Introduction

Globus Pallidus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The globus pallidus (Latin: "pale globe") is a subcortical structure of the basal-ganglia that serves as the primary output nucleus for motor information processed by the striatum. Located medial to the putamen and lateral to the internal capsule, it consists of two functionally distinct segments: the globus pallidus externus (GPe, or lateral segment) and the globus pallidus internus (GPi, or medial segment). [@vitek2012]
The GPi, together with the substantia-nigra pars reticulata (SNr), provides the final basal ganglia output to the thalamus and brainstem, tonically inhibiting thalamo-cortical activity through GABAergic projections.[@parent2020] [@abdi2015]

The globus pallidus is clinically significant in multiple neurodegenerative diseases and is a major therapeutic target for [deep-brain-stimulation](/therapeutics/deep-brain-stimulation) (DBS). GPi-DBS is a well-established treatment for parkinsons motor complications, dystonia, and huntington-pathway chorea. [@hallgren1958]
Pathological changes in the globus pallidus occur in Parkinson's Disease, Huntington's Disease, psp, neurodegeneration with brain iron accumulation (NBIA), Wilson's Disease, and other basal ganglia disorders.[@vitek2012] [@delong1990]

Anatomy

Segments

The globus pallidus is divided into two segments by the internal (medial) medullary lamina: [@mulcahy2023]

Globus Pallidus Externus (GPe): [@gpidbs2025]

• Receives inhibitory GABAergic input from D2-expressing medium-spiny-neurons of the striatum (indirect pathway)
• Projects to the subthalamic-nucleus (STN), forming the critical GPe–STN reciprocal circuit
• Also sends projections back to the striatum (pallidostriatal pathway) and directly to GPi (bridging collaterals)
• Contains two main neuron populations: prototypic neurons (projecting to STN, ~70% of GPe neurons and arkypallidal neurons (projecting back to striatum, ~30% of GPe neurons) — a distinction revealed by single-cell transcriptomics and optogenetic mapping[@abdi2015]
• Functions as a central "hub" of the basal ganglia, integrating and processing information within the indirect pathway

• The primary output nucleus of the basal ganglia (along with SNr)
• Receives excitatory glutamatergic input from the STN (indirect/hyperdirect pathways) and inhibitory GABAergic input from D1-expressing medium-spiny-neurons (direct pathway)
• Projects to the ventrolateral (VL) and ventral anterior (VA) nuclei of the thalamus, which relay motor information to the motor-cortex and premotor cortex
• Also projects to the pedunculopontine-nucleus (PPN) in the brainstem, influencing locomotion and posture
• GPi neurons fire tonically at high rates (~70–80 Hz), providing constant inhibition of thalamic relay neurons. Movement occurs when GPi inhibition is transiently paused by direct pathway input

Cellular Properties

Globus pallidus neurons are large, multipolar GABAergic neurons with extensive dendritic arbors. Key features: [@williams2009]

• High firing rate: GPi neurons fire tonically at 60–80 Hz (GPe at 40–60 Hz), among the highest baseline rates in the brain
• Parvalbumin expression: Most pallidal neurons express parvalbumin and fire in fast, regular patterns
• Myelinated appearance: The pale color of the globus pallidus (giving it its name) results from the dense myelinated fibers passing through it, contributed by both afferent and efferent projections
• High metabolic demand: The continuous high-frequency firing of pallidal neurons requires substantial mitochondrial ATP production, making these cells susceptible to mitochondrial-dysfunction and oxidative-stress
• Iron content: The globus pallidus has the highest physiological iron concentration of any brain structure, which increases with aging and is relevant to NBIA disorders[@hallgren1958]

Vascular Supply

The globus pallidus receives its blood supply from the anterior choroidal artery and lenticulostriate arteries (branches of the middle cerebral artery). This vascular territory is susceptible to: [@hayflick2003]

• Carbon monoxide poisoning (bilateral pallidal necrosis)
• Kernicterus (bilirubin-mediated pallidal damage)
• Hepatic failure (manganese deposition producing T1-hyperintense signal)

Function

Motor Circuit Integration

The globus pallidus integrates the output of the direct, indirect, and hyperdirect pathways:[@delong1990] [@aylward2011]

In normal function, the dynamic interplay between these pathways allows for the precise selection and execution of desired movements while suppressing unwanted ones. [@helmich2021]

GPe as a Central Pacemaker

Recent research has revealed that the GPe is not merely a relay within the indirect pathway but functions as an autonomous pacemaker and integrator:[@abdi2015] [@allen]

• GPe neurons exhibit intrinsic oscillatory activity and can generate beta-frequency oscillations (13–30 Hz) that become pathologically enhanced in parkinsons
• The GPe–STN reciprocal circuit is a critical node for generating and propagating pathological oscillations that underlie parkinsonian motor symptoms
• Prototypic GPe neurons provide patterned inhibition to STN that shapes motor output, while arkypallidal neurons project back to striatum to modulate input
• Disruption of the GPe prototypic/arkypallidal balance is implicated in the pathological oscillations characteristic of PD

Non-Motor Functions

Beyond motor control, the globus pallidus participates in: [@brainspan]

• Cognitive circuits: The associative territory of GPi (receiving from caudate via direct pathway) processes cognitive information relevant to decision-making and habit formation
• Limbic circuits: The ventral pallidum (below the anterior commissure) processes reward and motivational information from the nucleus-accumbens
• Sleep regulation: Pallidal GABAergic output influences sleep-wake transitions via thalamic and brainstem projections
• Pain processing: The GPi receives nociceptive input and pallidal DBS can modulate pain perception in chronic pain syndromes

Role in Neurodegenerative Diseases

Parkinson's Disease

In parkinsons, dopamine depletion in the putamen causes a cascade of changes in pallidal activity:[@delong1990] [@neurosynth]

• GPe: Hypoactive due to increased D2-MSN inhibition (indirect pathway overactivation). Reduced GPe activity leads to STN disinhibition
• GPi: Hyperactive due to increased STN excitation and reduced D1-MSN inhibition (direct pathway underactivation). Elevated GPi firing rates cause excessive inhibition of thalamo-cortical circuits, producing akinesia/bradykinesia
• Pathological oscillations: Loss of dopaminergic modulation leads to exaggerated beta-band (13-30 Hz) synchronization in the GPe-STN-GPi circuit, which correlates with movement slowness and can be recorded from DBS electrodes

• GPi-DBS: High-frequency stimulation of GPi disrupts pathological firing patterns, reducing motor symptoms. GPi-DBS is particularly effective for reducing dyskinesia and medication-related motor fluctuations in advanced PD.

• GPi-DBS mechanism: A 2025 study using diffusion tensor imaging demonstrated that GPi-DBS effects propagate along physiological white matter pathways to the thalamus and subthalamic nucleus, confirming that stimulation modulates entire basal ganglia-thalamocortical circuits rather than simply lesioning the GPi[@gpidbs2025]
• Pallidotomy: Surgical lesioning of GPi was the treatment of choice before DBS and remains an option when DBS is not available or affordable

Huntington's Disease

The globus pallidus shows significant pathology in huntington-pathway:[@gonzalez2014]

• Chorea mechanism: Early preferential loss of indirect pathway (D2) medium-spiny-neurons in the striatum reduces GPe inhibition, which in turn reduces STN activity and GPi output, causing the hyperkinetic chorea characteristic of early HD. As the disease progresses, both D1 and D2 MSNs are lost, leading to a mixed hyperkinetic-hypokinetic phenotype
• Pallidal atrophy: MRI volumetrics show pallidal atrophy beginning approximately 3 years before estimated motor onset in premanifest HD gene carriers, making it a potential predictive biomarker
• GPi-DBS for HD chorea: [deep-brain-stimulation](/therapeutics/deep-brain-stimulation) of GPi has shown promising results for managing severe, medication-refractory chorea, with sustained benefit at 4+ years follow-up. However, DBS does not slow the underlying neurodegeneration and cognitive decline continues
• htt-protein aggregates: Mutant huntingtin inclusions are found in pallidal neurons, contributing to cell dysfunction and death

Progressive Supranuclear Palsy

In psp, both GPi and GPe show tau] pathology — neurofibrillary tangles, tufted astrocytes, and neuropil threads. Pallidal tau] pathology contributes to the axial rigidity, postural instability, and falls that characterize PSP.
Unlike PD, where pallidal dysfunction results from dopamine depletion, PSP involves direct neuronal loss within the pallidum itself, making the pathophysiology fundamentally different and limiting the efficacy of levodopa therapy.[@williams2009]

Neurodegeneration with Brain Iron Accumulation (NBIA)

The globus pallidus is the primary site of iron accumulation in NBIA disorders:[@hayflick2003]

• PKAN (pantothenate kinase-associated neurodegeneration): Bilateral iron deposition in GPi produces the pathognomonic "eye of the tiger" sign on T2-weighted MRI — a central hyperintensity (gliosis/vacuolation) surrounded by hypointensity (iron deposition) in the GPi. Caused by mutations in the PANK2 gene, which encodes an enzyme essential for coenzyme A biosynthesis
• PLAN (PLA2G6-associated neurodegeneration): Pallidal iron deposition with progressive dystonia and cognitive decline
• MPAN (mitochondrial membrane protein-associated neurodegeneration): C19orf12 mutations with pallidal iron and optic atrophy
• BPAN (beta-propeller protein-associated neurodegeneration): WDR45 mutations with distinctive childhood static encephalopathy followed by adult-onset parkinsonism-dystonia
• Neuroferritinopathy: FTL (ferritin light chain) mutations with progressive pallidal cavitation
• Aceruloplasminemia: Ceruloplasmin deficiency causing systemic iron overload including severe pallidal deposition

Wilson's Disease

In Wilson's Disease (hepatolenticular degeneration), copper deposition in the globus pallidus and putamen causes the characteristic "face of the giant panda" sign on T2-weighted MRI (hyperintensity in the tegmentum with hypointense superior colliculi and preserved red nuclei). Pallidal copper deposition contributes to dystonia and parkinsonian features. Copper chelation therapy (penicillamine, trientine) and zinc supplementation can reverse some pallidal changes if initiated early.

Corticobasal Degeneration

In corticobasal-degeneration, the globus pallidus shows asymmetric tau] pathology (astrocytic plaques and ballooned neurons) that correlates with the asymmetric limb rigidity and alien limb phenomena characteristic of this disorder.

Manganism

Chronic manganese exposure (welding, mining, parenteral nutrition) causes selective pallidal toxicity, producing a parkinsonian syndrome with prominent dystonia. T1-weighted MRI shows bilateral pallidal hyperintensity (due to manganese's paramagnetic properties) — a distinctive pattern that distinguishes manganism from idiopathic PD.

Imaging

The globus pallidus has distinctive imaging characteristics:[@hallgren1958]

• T2-weighted MRI: Normally appears hypointense (dark) due to physiological iron deposition that increases with age. Abnormal signal patterns (hyperintensity, the "eye of the tiger") indicate pathological iron deposition or gliosis
• T1-weighted MRI: Normally isointense; hyperintensity suggests manganese deposition (hepatic encephalopathy, manganism) or calcification
• Quantitative susceptibility mapping (QSM): Quantifies pallidal iron content with high precision; useful for monitoring NBIA disorders, tracking normal aging, and assessing ferroptosis-related neurodegeneration
• [pet-imaging](/diagnostics/pet-imaging): GABA-A receptor PET (11C-flumazenil) can quantify pallidal neuronal loss; 18F-FDG PET reveals altered pallidal metabolism in movement disorders. Dopamine D2 receptor PET (11C-raclopride) shows altered pallidal receptor binding in dystonia
• Functional MRI: Task-based and resting-state fMRI reveal pallidal activation during motor planning, action selection, and reward-based decision making
• DBS electrode imaging: Post-operative CT or MRI verification of DBS lead placement in GPi is critical for optimizing stimulation parameters and clinical outcomes
• medium-spiny-neurons
• [deep-brain-stimulation](/therapeutics/deep-brain-stimulation)

External Links

• [Allen Human Brain Atlas - GPe Gene Expression](https://human.brain-map.org/)allen-human-brain-atlas)
• [NCBI Gene: PANK2](https://www.ncbi.nlm.nih.gov/gene/80025)
• [NCBI Gene: PLA2G6](https://www.ncbi.nlm.nih.gov/gene/8398)
• [UniProt - Ferritin Light Chain (P02792)](https://www.uniprot.org/uniprot/P02792)

Brain Atlas Resources

• Allen Human Brain Atlas: [Globus Pallidus expression search](https://human.brain-map.org/microarray/search/show?search_term=Globus+Pallidus)
• Allen Mouse Brain Atlas: [Globus Pallidus search](https://mouse.brain-map.org/search/index.html?query=Globus+Pallidus)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
• BrainSpan Developmental Transcriptome: [Globus Pallidus developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=Globus+Pallidus)

Background

The study of Globus Pallidus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Globus Pallidus discovered through SciDEX knowledge graph analysis: